Literature DB >> 15111780

Serum lipid alterations in acute lymphoblastic leukemia of childhood.

Maria Moschovi1, Georgios Trimis, Filia Apostolakou, Ioannis Papassotiriou, Fotini Tzortzatou-Stathopoulou.   

Abstract

Epidemiologic studies have indicated a relationship between serum lipids and cancer, and it is possible that lipid abnormalities are involved in the mechanism of oncogenesis. This study was performed to investigate serum lipid alterations in patients with acute lymphoblastic leukemia (ALL) at diagnosis and during remission of the disease. Plasma lipids and lipoproteins were measured at diagnosis, prior to the administration of induction treatment, and every 2 months for the first 12 months of the maintenance phase of chemotherapy in 64 patients with ALL. Nearly all patients demonstrated a predictable pattern of serum lipid alterations that consisted of extremely low levels of high-density lipoprotein cholesterol, elevated triglycerides, and elevated low-density lipoprotein cholesterol. Patients studied again during remission demonstrated a return to normal values, and the difference was statistically significant. The results suggest that at diagnosis of ALL an abnormality in lipid metabolism is present, which is reversed during remission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111780     DOI: 10.1097/00043426-200405000-00006

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  11 in total

1.  Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy.

Authors:  Su-Min Jeong; Taewoong Choi; Dahye Kim; Kyungdo Han; Seok Jin Kim; Sang Youl Rhee; Edward L Giovannucci; Dong Wook Shin
Journal:  Leukemia       Date:  2020-12-02       Impact factor: 11.528

2.  Genome-wide linkage and positional association analyses identify associations of novel AFF3 and NTM genes with triglycerides: the GenSalt study.

Authors:  Changwei Li; Lydia A L Bazzano; Dabeeru C Rao; James E Hixson; Jiang He; Dongfeng Gu; Charles C Gu; Lawrence C Shimmin; Cashell E Jaquish; Karen Schwander; De-Pei Liu; Jianfeng Huang; Fanghong Lu; Jie Cao; Shen Chong; Xiangfeng Lu; Tanika N Kelly
Journal:  J Genet Genomics       Date:  2015-02-17       Impact factor: 4.275

3.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger
Journal:  Eur J Cancer       Date:  2014-07-30       Impact factor: 9.162

4.  Low HDL levels and the risk of death, sepsis and malignancy.

Authors:  Renana Shor; Julio Wainstein; David Oz; Mona Boaz; Zipora Matas; Asora Fux; Aaron Halabe
Journal:  Clin Res Cardiol       Date:  2007-12-01       Impact factor: 5.460

5.  Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms.

Authors:  Cliona M McHale; Luoping Zhang; Qing Lan; Guilan Li; Alan E Hubbard; Matthew S Forrest; Roel Vermeulen; Jinsong Chen; Min Shen; Stephen M Rappaport; Songnian Yin; Martyn T Smith; Nathaniel Rothman
Journal:  Genomics       Date:  2009-01-20       Impact factor: 5.736

Review 6.  Targeted nanoparticles for pediatric leukemia therapy.

Authors:  Riyaz Basha; Nirupama Sabnis; Kenneth Heym; W Paul Bowman; Andras G Lacko
Journal:  Front Oncol       Date:  2014-05-13       Impact factor: 6.244

7.  The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  Peter M Alexander; David L Caudell; Gregory L Kucera; Kristin M Pladna; Timothy S Pardee
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

8.  iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia.

Authors:  Runhong Yu; Jingyu Zhang; Yuzhu Zang; Li Zeng; Wenli Zuo; Yanliang Bai; Yanhui Liu; Kai Sun; Yufeng Liu
Journal:  Cancer Manag Res       Date:  2019-07-25       Impact factor: 3.989

9.  Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.

Authors:  Pernille Rudebeck Mogensen; Kathrine Grell; Kjeld Schmiegelow; Ulrik Malthe Overgaard; Benjamin Ole Wolthers; Signe Sloth Mogensen; Allan Vaag; Thomas Leth Frandsen
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

10.  Lipid changes occuring in the course of hematological cancers.

Authors:  Małgorzata Kuliszkiewicz-Janus; Rafał Małecki; Abdulrahman Saeed Mohamed
Journal:  Cell Mol Biol Lett       Date:  2008-05-06       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.